{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T10:25:41Z","timestamp":1782123941723,"version":"3.54.5"},"update-to":[{"DOI":"10.1002\/14651858.cd010137","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,6,8]],"date-time":"2017-06-08T00:00:00Z","timestamp":1496880000000}}],"reference-count":234,"publisher":"Wiley","issue":"6","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd010137.pub2","type":"journal-article","created":{"date-parts":[[2017,6,8]],"date-time":"2017-06-08T06:41:48Z","timestamp":1496904108000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Glucose targets for preventing diabetic kidney disease and its progression"],"prefix":"10.1002","volume":"2017","author":[{"given":"Marinella","family":"Ruospo","sequence":"first","affiliation":[{"name":"Diaverum; Medical Scientific Office; Lund Sweden"},{"name":"Amedeo Avogadro University of Eastern Piedmont; Division of Nephrology and Transplantation, Department of Translational Medicine; Via Solaroli 17 Novara Italy 28100"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria M","family":"Saglimbene","sequence":"additional","affiliation":[{"name":"Diaverum; Medical Scientific Office; Lund Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suetonia C","family":"Palmer","sequence":"additional","affiliation":[{"name":"University of Otago Christchurch; Department of Medicine; 2 Riccarton Ave PO Box 4345 Christchurch New Zealand 8140"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"De Cosmo","sequence":"additional","affiliation":[{"name":"Scientific Institute CSS; Department of Medicine; Viale Cappuccini San Giovanni Rotondo Italy 71013"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Pacilli","sequence":"additional","affiliation":[{"name":"Scientific Institute CSS; Department of Medicine; Viale Cappuccini San Giovanni Rotondo Italy 71013"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Lamacchia","sequence":"additional","affiliation":[{"name":"University of Foggia; Department of Endocrinology; Foggia Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Cignarelli","sequence":"additional","affiliation":[{"name":"University of Foggia; Department of Endocrinology; Foggia Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Fioretto","sequence":"additional","affiliation":[{"name":"University of Padova; Department of Medicine; Padova Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariacristina","family":"Vecchio","sequence":"additional","affiliation":[{"name":"Danone Research; RD 128 Palaiseau Cedex France 91767"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan C","family":"Craig","sequence":"additional","affiliation":[{"name":"The University of Sydney; Sydney School of Public Health; Edward Ford Building A27 Sydney NSW Australia 2006"},{"name":"The Children's Hospital at Westmead; Cochrane Kidney and Transplant, Centre for Kidney Research; Westmead NSW Australia 2145"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni FM","family":"Strippoli","sequence":"additional","affiliation":[{"name":"Diaverum; Medical Scientific Office; Lund Sweden"},{"name":"The Children's Hospital at Westmead; Cochrane Kidney and Transplant, Centre for Kidney Research; Westmead NSW Australia 2145"},{"name":"University of Bari; Department of Emergency and Organ Transplantation; Bari Italy"},{"name":"Diaverum Academy; Bari Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,6,8]]},"reference":[{"issue":"3","key":"10.1002\/14651858.CD010137.pub2-BIB0001|cit1","first-page":"233","article-title":"Effects of medical therapies on retinopathy progression in type 2 diabetes.[Erratum appears in N Engl J Med. 2011 Jan 13;364(2):190], [Erratum appears in N Engl J Med. 2012 Dec 20;367(25):2458]","volume":"363","author":"Chew","year":"2010","journal-title":"New England Journal of Medicine"},{"issue":"12A","key":"10.1002\/14651858.CD010137.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"21i","DOI":"10.1016\/j.amjcard.2007.03.003","article-title":"Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: design and methods","volume":"99","author":"Buse","year":"2007","journal-title":"American Journal of Cardiology"},{"issue":"17","key":"10.1002\/14651858.CD010137.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJMoa1001286","article-title":"Effects of intensive blood-pressure control in type 2 diabetes mellitus","volume":"362","author":"Cushman","year":"2010","journal-title":"New England Journal of Medicine"},{"issue":"9","key":"10.1002\/14651858.CD010137.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1056\/NEJMoa1006524","article-title":"Long-term effects of intensive glucose lowering on cardiovascular outcomes","volume":"364","author":"Gerstein","year":"2011","journal-title":"New England Journal of Medicine"},{"issue":"17","key":"10.1002\/14651858.CD010137.pub2-BIB0005|cit5","first-page":"1563","article-title":"Effects of combination lipid therapy in type 2 diabetes mellitus.[Erratum appears in N Engl J Med. 2010 May 6;362(18):1748]","volume":"362","author":"Ginsberg","year":"2010","journal-title":"New England Journal of Medicine"},{"issue":"24","key":"10.1002\/14651858.CD010137.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa0802743","article-title":"Effects of intensive glucose lowering in type 2 diabetes","volume":"358","author":"Gerstein","year":"2008","journal-title":"New England Journal of Medicine"},{"issue":"7","key":"10.1002\/14651858.CD010137.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.2337\/dc11-1827","article-title":"Intensive blood pressure treatment does not improve cardiovascular outcomes in centrally obese hypertensive individuals with diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Blood Pressure Trial","volume":"35","author":"Barzilay","year":"2012","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1002\/14651858.CD010137.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.2215\/CJN.11321112","article-title":"Albuminuria and cognitive decline in people with diabetes and normal renal function","volume":"8","author":"Barzilay","year":"2013","journal-title":"Clinical Journal of the American Society of Nephrology: CJASN"},{"issue":"6","key":"10.1002\/14651858.CD010137.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1007\/s00125-012-2524-2","article-title":"Fenofibrate-associated changes in renal function and relationship to clinical outcomes among individuals with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) experience","volume":"55","author":"Bonds","year":"2012","journal-title":"Diabetologia"},{"issue":"12A","key":"10.1002\/14651858.CD010137.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"80i","DOI":"10.1016\/j.amjcard.2007.03.026","article-title":"Severe hypoglycemia monitoring and risk management procedures in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial","volume":"99","author":"Bonds","year":"2007","journal-title":"American Journal of Cardiology"},{"key":"10.1002\/14651858.CD010137.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"b4909","DOI":"10.1136\/bmj.b4909","article-title":"The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study","volume":"340","author":"Bonds","year":"2010","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD010137.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1472-6823-12-5","article-title":"Severe hypoglycemia symptoms, antecedent behaviors, immediate consequences and association with glycemia medication usage: Secondary analysis of the ACCORD clinical trial data","volume":"12","author":"Bonds","year":"2012","journal-title":"BMC Endocrine Disorders"},{"issue":"12A","key":"10.1002\/14651858.CD010137.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"103i","DOI":"10.1016\/j.amjcard.2007.03.028","article-title":"Rationale, design, and methods of the Action to Control Cardiovascular Risk in Diabetes Eye Study (ACCORD-EYE)","volume":"99","author":"Chew","year":"2007","journal-title":"American Journal of Cardiology"},{"issue":"12A","key":"10.1002\/14651858.CD010137.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"44i","DOI":"10.1016\/j.amjcard.2007.03.005","article-title":"Rationale and design for the blood pressure intervention of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial","volume":"99","author":"Cushman","year":"2007","journal-title":"American Journal of Cardiology"},{"issue":"8","key":"10.1002\/14651858.CD010137.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.amjcard.2014.07.045","article-title":"Impact of intensive glycemic control on the incidence of atrial fibrillation and associated cardiovascular outcomes in patients with type 2 diabetes mellitus (from the Action to Control Cardiovascular Risk in Diabetes Study)","volume":"114","author":"Fatemi","year":"2014","journal-title":"American Journal of Cardiology"},{"issue":"8","key":"10.1002\/14651858.CD010137.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.2337\/dc12-1391","article-title":"Determinants of weight gain in the action to control cardiovascular risk in diabetes trial","volume":"36","author":"Fonseca","year":"2013","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1002\/14651858.CD010137.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1210\/jc.2011-1679","article-title":"Clinical implications of the ACCORD trial","volume":"97","author":"Genuth","year":"2012","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"issue":"5","key":"10.1002\/14651858.CD010137.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.2337\/dc12-1311","article-title":"Diabetic retinopathy, its progression, and incident cardiovascular events in the ACCORD trial","volume":"36","author":"Gerstein","year":"2013","journal-title":"Diabetes Care"},{"issue":"9958","key":"10.1002\/14651858.CD010137.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1016\/S0140-6736(14)60611-5","article-title":"Effects of intensive glycaemic control on ischaemic heart disease: analysis of data from the randomised, controlled ACCORD trial","volume":"384","author":"Gerstein","year":"2014","journal-title":"Lancet"},{"issue":"12A","key":"10.1002\/14651858.CD010137.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"34i","DOI":"10.1016\/j.amjcard.2007.03.004","article-title":"Glycemia treatment strategies in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial","volume":"99","author":"Gerstein","year":"2007","journal-title":"American Journal of Cardiology"},{"issue":"12A","key":"10.1002\/14651858.CD010137.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"56i","DOI":"10.1016\/j.amjcard.2007.03.024","article-title":"Evolution of the lipid trial protocol of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial","volume":"99","author":"Ginsberg","year":"2007","journal-title":"American Journal of Cardiology"},{"issue":"12A","key":"10.1002\/14651858.CD010137.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"4i","DOI":"10.1016\/j.amjcard.2007.03.002","article-title":"Prevention of cardiovascular disease in persons with type 2 diabetes mellitus: current knowledge and rationale for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial","volume":"99","author":"Goff","year":"2007","journal-title":"American Journal of Cardiology"},{"key":"10.1002\/14651858.CD010137.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.bone.2015.04.037","article-title":"Change in estimated glomerular filtration rate and fracture risk in the Action to Control Cardiovascular Risk in Diabetes Trial","volume":"78","author":"Isakova","year":"2015","journal-title":"Bone"},{"issue":"9739","key":"10.1002\/14651858.CD010137.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0140-6736(10)60576-4","article-title":"Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial.[Erratum appears in Lancet. 2010 Oct 30;376(9751):1466]","volume":"376","author":"Ismail-Beigi","year":"2010","journal-title":"Lancet"},{"issue":"6","key":"10.1002\/14651858.CD010137.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/ki.2011.415","article-title":"Combined intensive blood pressure and glycemic control does not produce an additive benefit on microvascular outcomes in type 2 diabetic patients","volume":"81","author":"Ismail-Beigi","year":"2012","journal-title":"Kidney International"},{"issue":"12A","key":"10.1002\/14651858.CD010137.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"68i","DOI":"10.1016\/j.amjcard.2007.03.025","article-title":"Recruitment strategies in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial","volume":"99","author":"Kingry","year":"2007","journal-title":"American Journal of Cardiology"},{"issue":"3","key":"10.1002\/14651858.CD010137.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"686","DOI":"10.2337\/dc13-0790","article-title":"Paradoxical reduction in HDL-C with fenofibrate and thiazolidinedione therapy in type 2 diabetes: the ACCORD Lipid Trial","volume":"37","author":"Linz","year":"2014","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1002\/14651858.CD010137.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.2337\/dc13-2334","article-title":"Outcomes of combined cardiovascular risk factor management strategies in type 2 diabetes: the ACCORD randomized trial","volume":"37","author":"Margolis","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1002\/14651858.CD010137.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"859","DOI":"10.2147\/VHRM.S4808","article-title":"Cardiovascular disease and intensive glucose control in type 2 diabetes mellitus: moving practice toward evidence-based strategies","volume":"5","author":"Meier","year":"2009","journal-title":"Vascular Health & Risk Management"},{"key":"10.1002\/14651858.CD010137.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"b5444","DOI":"10.1136\/bmj.b5444","article-title":"The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study","volume":"340","author":"Miller","year":"2010","journal-title":"BMJ"},{"issue":"3","key":"10.1002\/14651858.CD010137.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"634","DOI":"10.2337\/dc13-1545","article-title":"Effects of randomization to intensive glucose control on adverse events, cardiovascular disease, and mortality in older versus younger adults in the ACCORD Trial","volume":"37","author":"Miller","year":"2014","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1002\/14651858.CD010137.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.jdiacomp.2014.07.001","article-title":"The degree of retinopathy is equally predictive for renal and macrovascular outcomes in the ACCORD Trial","volume":"28","author":"Mottl","year":"2014","journal-title":"Journal of Diabetes & its Complications"},{"issue":"5","key":"10.1002\/14651858.CD010137.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.2337\/dc11-1811","article-title":"Reversibility of fenofibrate therapy-induced renal function impairment in ACCORD type 2 diabetic participants","volume":"35","author":"Mychaleckyj","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1002\/14651858.CD010137.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1479-5876-9-91","article-title":"Buffy coat specimens remain viable as a DNA source for highly multiplexed genome-wide genetic tests after long term storage","volume":"9","author":"Mychaleckyj","year":"2011","journal-title":"Journal of Translational Medicine"},{"issue":"8","key":"10.1002\/14651858.CD010137.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.2215\/CJN.12051115","article-title":"Association of urinary biomarkers of inflammation, injury, and fibrosis with renal function decline: The ACCORD Trial","volume":"11","author":"Nadkarni","year":"2016","journal-title":"Clinical Journal of the American Society of Nephrology: CJASN"},{"issue":"3","key":"10.1002\/14651858.CD010137.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/ki.2014.296","article-title":"Chronic kidney disease and intensive glycemic control increase cardiovascular risk in patients with type 2 diabetes","volume":"87","author":"Papademetriou","year":"2015","journal-title":"Kidney International"},{"issue":"7","key":"10.1002\/14651858.CD010137.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.2337\/dc10-0125","article-title":"Effects of cardiac autonomic dysfunction on mortality risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial","volume":"33","author":"Pop-Busui","year":"2010","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1002\/14651858.CD010137.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"787","DOI":"10.2337\/dc11-1855","article-title":"Poor cognitive function and risk of severe hypoglycemia in type 2 diabetes: post hoc epidemiologic analysis of the ACCORD trial","volume":"35","author":"Punthakee","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1002\/14651858.CD010137.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1475-2840-11-35","article-title":"Baseline comparison of three health utility measures and the feeling thermometer among participants in the Action to Control Cardiovascular Risk in Diabetes trial","volume":"11","author":"Raisch","year":"2012","journal-title":"Cardiovascular Diabetology"},{"issue":"2","key":"10.1002\/14651858.CD010137.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"422","DOI":"10.2337\/dc11-2556","article-title":"Effect of combination therapy with fenofibrate and simvastatin on postprandial lipemia in the ACCORD lipid trial","volume":"36","author":"Reyes-Soffer","year":"2013","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1002\/14651858.CD010137.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"983","DOI":"10.2337\/dc09-1278","article-title":"Epidemiologic relationships between A1C and all-cause mortality during a median 3.4-year follow-up of glycemic treatment in the ACCORD trial","volume":"33","author":"Riddle","year":"2010","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1002\/14651858.CD010137.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.diabres.2011.09.027","article-title":"The effect of intensive risk factor management in type 2 diabetes on inflammatory biomarkers","volume":"95","author":"Samaropoulos","year":"2012","journal-title":"Diabetes Research & Clinical Practice"},{"issue":"2","key":"10.1002\/14651858.CD010137.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2337\/dc11-0996","article-title":"The impact of frequent and unrecognized hypoglycemia on mortality in the ACCORD study","volume":"35","author":"Seaquist","year":"2012","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1002\/14651858.CD010137.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1177\/1740774510372779","article-title":"Evaluation of an automated method to assist with error detection in the ACCORD central laboratory","volume":"7","author":"Strylewicz","year":"2010","journal-title":"Clinical Trials"},{"issue":"12A","key":"10.1002\/14651858.CD010137.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"90i","DOI":"10.1016\/j.amjcard.2007.03.027","article-title":"Health-related quality of life and cost-effectiveness components of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: rationale and design","volume":"99","author":"Sullivan","year":"2007","journal-title":"American Journal of Cardiology"},{"issue":"8","key":"10.1002\/14651858.CD010137.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.2337\/dc11-1791","article-title":"Depression predicts all-cause mortality: epidemiological evaluation from the ACCORD HRQL substudy","volume":"35","author":"Sullivan","year":"2012","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1002\/14651858.CD010137.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1373\/clinchem.2010.155887","article-title":"Urinary catalytic iron in patients with type 2 diabetes without microalbuminuria--a substudy of the ACCORD Trial","volume":"57","author":"Thethi","year":"2011","journal-title":"Clinical Chemistry"},{"issue":"3","key":"10.1002\/14651858.CD010137.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1001\/jamainternmed.2013.13656","article-title":"Cognitive function and brain structure in persons with type 2 diabetes mellitus after intensive lowering of blood pressure and lipid levels: a randomized clinical trial","volume":"174","author":"Williamson","year":"2014","journal-title":"JAMA Internal Medicine"},{"issue":"12A","key":"10.1002\/14651858.CD010137.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"112i","DOI":"10.1016\/j.amjcard.2007.03.029","article-title":"The Action to Control Cardiovascular Risk in Diabetes Memory in Diabetes Study (ACCORD-MIND): rationale, design, and methods","volume":"99","author":"Williamson","year":"2007","journal-title":"American Journal of Cardiology"},{"issue":"4","key":"10.1002\/14651858.CD010137.pub2-BIB0071|cit50","first-page":"S21","article-title":"Rationale and design of the ADVANCE study: a randomised trial of blood pressure lowering and intensive glucose control in high-risk individuals with type 2 diabetes mellitus. Action in Diabetes and Vascular Disease: Preterax and diamicron modified-release controlled evaluation","volume":"19","year":"2001","journal-title":"Journal of Hypertension - Supplement"},{"issue":"7","key":"10.1002\/14651858.CD010137.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1111\/j.1464-5491.2005.01596.x","article-title":"ADVANCE--Action in Diabetes and Vascular Disease: patient recruitment and characteristics of the study population at baseline","volume":"22","author":"ADVANCE Collaborative Group","year":"2005","journal-title":"Diabetic Medicine"},{"issue":"24","key":"10.1002\/14651858.CD010137.pub2-BIB0050|cit52","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","article-title":"Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes","volume":"358","author":"Patel","year":"2008","journal-title":"New England Journal of Medicine"},{"issue":"9","key":"10.1002\/14651858.CD010137.pub2-BIB0052|cit53","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1007\/s001250100612","article-title":"Study rationale and design of ADVANCE: action in diabetes and vascular disease--Preterax and Diamicron MR Controlled Evaluation","volume":"44","author":"ADVANCE Management Committee","year":"2001","journal-title":"Diabetologia"},{"issue":"1","key":"10.1002\/14651858.CD010137.pub2-BIB0053|cit54","doi-asserted-by":"crossref","first-page":"e009668","DOI":"10.1136\/bmjopen-2015-009668","article-title":"The harms of smoking and benefits of smoking cessation in women compared with men with type 2 diabetes: an observational analysis of the ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron modified release Controlled Evaluation) trial","volume":"6","author":"Blomster","year":"2016","journal-title":"BMJ Open"},{"issue":"Spec No 1","key":"10.1002\/14651858.CD010137.pub2-BIB0056|cit55","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2165\/00003495-200363991-00005","article-title":"ADVANCE study: objectives, design and current status","volume":"63","author":"Chalmers","year":"2003","journal-title":"Drugs"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD010137.pub2-BIB0054|cit56","first-page":"S354","article-title":"The efficacy of lowering HbAlc with a gliclazide modified release-based intensive glucose lowering regimen in the ADVANCE trial [abstract]","volume":"52","author":"Chalmers","year":"2009","journal-title":"Diabetologia"},{"issue":"5","key":"10.1002\/14651858.CD010137.pub2-BIB0055|cit57","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1097\/01.hjh.0000240043.50838.28","article-title":"ADVANCE: breaking new ground in type 2 diabetes","volume":"24","author":"Chalmers","year":"2006","journal-title":"Journal of Hypertension - Supplement"},{"issue":"1 Suppl","key":"10.1002\/14651858.CD010137.pub2-BIB0057|cit58","first-page":"S442","article-title":"Risk of major renal events in people with type 2 diabetes: prediction models based on the ADVANCE study population [abstract]","volume":"54","author":"Cooper","year":"2011","journal-title":"Diabetologia"},{"issue":"12","key":"10.1002\/14651858.CD010137.pub2-BIB0058|cit59","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1161\/CIRCULATIONAHA.113.002717","article-title":"Effects of visit-to-visit variability in systolic blood pressure on macrovascular and microvascular complications in patients with type 2 diabetes mellitus: the ADVANCE trial","volume":"128","author":"Hata","year":"2013","journal-title":"Circulation"},{"issue":"23","key":"10.1002\/14651858.CD010137.pub2-BIB0059|cit60","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1093\/eurheartj\/ehq139","article-title":"Effects of a fixed combination of perindopril and indapamide in patients with type 2 diabetes and chronic kidney disease","volume":"31","author":"Heerspink","year":"2010","journal-title":"European Heart Journal"},{"issue":"Abstracts Issue","key":"10.1002\/14651858.CD010137.pub2-BIB0060|cit61","first-page":"543A","article-title":"Predictive baseline factors for major renal events: a proportional hazards model based on the ADVANCE Study [abstract no: F-PO1916]","volume":"19","author":"Jardine","year":"2008","journal-title":"Journal of the American Society of Nephrology"},{"issue":"5","key":"10.1002\/14651858.CD010137.pub2-BIB0061|cit62","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1053\/j.ajkd.2012.04.025","article-title":"Prediction of kidney-related outcomes in patients with type 2 diabetes","volume":"60","author":"Jardine","year":"2012","journal-title":"American Journal of Kidney Diseases"},{"issue":"1","key":"10.1002\/14651858.CD010137.pub2-BIB0062|cit63","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s12933-016-0446-x","article-title":"Presentations of major peripheral arterial disease and risk of major outcomes in patients with type 2 diabetes: results from the ADVANCE-ON study","volume":"15","author":"Mohammedi","year":"2016","journal-title":"Cardiovascular Diabetology"},{"issue":"6","key":"10.1002\/14651858.CD010137.pub2-BIB0063|cit64","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1097\/HJH.0b013e328338a89c","article-title":"Efficacy and safety of routine blood pressure lowering in older patients with diabetes: results from the ADVANCE trial","volume":"28","author":"Ninomiya","year":"2010","journal-title":"Journal of Hypertension"},{"issue":"9590","key":"10.1002\/14651858.CD010137.pub2-BIB0064|cit65","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0140-6736(07)61303-8","article-title":"Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial","volume":"370","author":"Patel","year":"2007","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD010137.pub2-BIB0065|cit66","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1038\/sj.jhh.1001890","article-title":"ADVANCE: action in diabetes and vascular disease","volume":"19 Suppl 1","author":"Patel","year":"2005","journal-title":"Journal of Human Hypertension"},{"issue":"3","key":"10.1002\/14651858.CD010137.pub2-BIB0066|cit67","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/ki.2012.401","article-title":"Intensive glucose control improves kidney outcomes in patients with type 2 diabetes","volume":"83","author":"Perkovic","year":"2013","journal-title":"Kidney International"},{"key":"10.1002\/14651858.CD010137.pub2-BIB0067|cit68","unstructured":"Perkovic V Ninomiya T de Galan BE Zoungas S Cass A Patel A Joint effects of routine blood pressure lowering and intensive glucose control in the ADVANCE trial [abstract no: LB-002] American Society of Nephrology (ASN) Renal Week; 2008 Nov 4-9; Philadelphia, PA 2008"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD010137.pub2-BIB0068|cit69","first-page":"42","article-title":"Intensive glucose lowering and end stage kidney disease - new data from the ADVANCE trial [abstract no: 071]","volume":"16","author":"Perkovic","year":"2011","journal-title":"Nephrology"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD010137.pub2-BIB0069|cit70","first-page":"A121","article-title":"Renoprotection with perindopril-indapamide below current recommended blood pressure targets in patients with type 2 diabetes mellitus: results of the ADVANCE trial [abstract no: 085]","volume":"13","author":"Perkovic","year":"2008","journal-title":"Nephrology"},{"issue":"1","key":"10.1002\/14651858.CD010137.pub2-BIB0070|cit71","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/01.hjh.0000354417.70192.be","article-title":"Blood pressure and glucose control in subjects with diabetes: new analyses from ADVANCE","volume":"27","author":"Poulter","year":"2009","journal-title":"Journal of Hypertension - Supplement"},{"issue":"8","key":"10.1002\/14651858.CD010137.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1093\/ndt\/gfs022","article-title":"The risk of cancer in people with diabetes and chronic kidney disease","volume":"27","author":"Wong","year":"2012","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"5","key":"10.1002\/14651858.CD010137.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"694","DOI":"10.2337\/dc15-2322","article-title":"Long-term benefits of intensive glucose control for preventing end-stage kidney disease: ADVANCE-ON","volume":"39","author":"Wong","year":"2016","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1002\/14651858.CD010137.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1007\/s00125-011-2404-1","article-title":"Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds","volume":"55","author":"Zoungas","year":"2012","journal-title":"Diabetologia"},{"issue":"1 Suppl","key":"10.1002\/14651858.CD010137.pub2-BIB0075|cit75","first-page":"S23","article-title":"Intensive glucose lowering and end stage kidney disease: new data from the ADVANCE trial [abstract]","volume":"54","author":"Zoungas","year":"2011","journal-title":"Diabetologia"},{"issue":"15","key":"10.1002\/14651858.CD010137.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1056\/NEJMoa1003795","article-title":"Severe hypoglycemia and risks of vascular events and death","volume":"363","author":"Zoungas","year":"2010","journal-title":"New England Journal of Medicine"},{"issue":"6","key":"10.1002\/14651858.CD010137.pub2-BIB0077|cit77","first-page":"1103","article-title":"Joint effects of blood pressure lowering and glucose control in the ADVANCE trial [abstract]","volume":"53","author":"Zoungas","year":"2009","journal-title":"Hypertension"},{"issue":"11","key":"10.1002\/14651858.CD010137.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.2337\/dc09-0959","article-title":"Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: new results from the ADVANCE trial","volume":"32","author":"Zoungas","year":"2009","journal-title":"Diabetes Care"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD010137.pub2-BIB0079|cit79","first-page":"A218","article-title":"Renoprotective effects of blood pressure lowering with perindopril-indapamide below current targets in people with type 2 diabetes mellitus: Results of the ADVANCE trial [abstract]","volume":"57","author":"Galan","year":"2008","journal-title":"Diabetes"},{"issue":"4","key":"10.1002\/14651858.CD010137.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1681\/ASN.2008070667","article-title":"Lowering blood pressure reduces renal events in type 2 diabetes","volume":"20","author":"Galan","year":"2009","journal-title":"Journal of the American Society of Nephrology"},{"issue":"1","key":"10.1002\/14651858.CD010137.pub2-BIB0081|cit81","first-page":"3","article-title":"Effect of long-term near-normoglycemia on the progression of diabetic nephropathy","volume":"11","author":"Ciavarella","year":"1985","journal-title":"Diabete et Metabolisme"},{"issue":"5","key":"10.1002\/14651858.CD010137.pub2-BIB0086|cit82","doi-asserted-by":"crossref","first-page":"530","DOI":"10.2337\/diab.35.5.530","article-title":"Diabetes Control and Complications Trial (DCCT). Design and methodologic considerations for the feasibility phase. The DCCT Research Group","volume":"35","year":"1986","journal-title":"Diabetes"},{"issue":"4","key":"10.1002\/14651858.CD010137.pub2-BIB0087|cit83","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2337\/diacare.13.4.427","article-title":"Diabetes Control and Complications Trial (DCCT). Update. DCCT Research Group","volume":"13","year":"1990","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1002\/14651858.CD010137.pub2-BIB0088|cit84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2337\/diacare.10.1.1","article-title":"Diabetes Control and Complications Trial (DCCT): results of feasibility study. The DCCT Research Group","volume":"10","year":"1987","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1002\/14651858.CD010137.pub2-BIB0090|cit85","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0022-3476(94)70190-3","article-title":"Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. Diabetes Control and Complications Trial Research Group","volume":"125","year":"1994","journal-title":"Journal of Pediatrics"},{"issue":"6","key":"10.1002\/14651858.CD010137.pub2-BIB0091|cit86","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/ki.1995.236","article-title":"Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial. The Diabetes Control and Complications (DCCT) Research Group","volume":"47","year":"1995","journal-title":"Kidney International"},{"issue":"6","key":"10.1002\/14651858.CD010137.pub2-BIB0112|cit87","first-page":"381","article-title":"Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. The Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications Research Group.[Erratum appears in N Engl J Med 2000 May 4;342(18):1376]","volume":"342","year":"2000","journal-title":"New England Journal of Medicine"},{"issue":"14","key":"10.1002\/14651858.CD010137.pub2-BIB0115|cit88","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group","volume":"329","year":"1993","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD010137.pub2-BIB0082|cit89","doi-asserted-by":"crossref","first-page":"218","DOI":"10.2337\/db07-1059","article-title":"Multiple superoxide dismutase 1\/splicing factor serine alanine 15 variants are associated with the development and progression of diabetic nephropathy: the Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications Genetics study","volume":"57","author":"Al-Kateb","year":"2008","journal-title":"Diabetes"},{"issue":"10","key":"10.1002\/14651858.CD010137.pub2-BIB0085|cit90","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S2213-8587(14)70155-X","article-title":"Effect of intensive diabetes treatment on albuminuria in type 1 diabetes: long-term follow-up of the Diabetes Control and Complications Trial and Epidemiology of Diabetes Interventions and Complications study","volume":"2","author":"DCCT\/EDIC Research Group","year":"2014","journal-title":"The Lancet Diabetes & Endocrinology"},{"issue":"18","key":"10.1002\/14651858.CD010137.pub2-BIB0083|cit91","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1056\/NEJMoa1409463","article-title":"Intensive diabetes therapy and ocular surgery in type 1 diabetes","volume":"372","author":"Aiello","year":"2015","journal-title":"New England Journal of Medicine"},{"issue":"25","key":"10.1002\/14651858.CD010137.pub2-BIB0084|cit92","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1056\/NEJMoa1111732","article-title":"Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes","volume":"365","author":"Boer","year":"2011","journal-title":"New England Journal of Medicine"},{"issue":"14","key":"10.1002\/14651858.CD010137.pub2-BIB0089|cit93","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1001\/archinternmed.2009.193","article-title":"Modern-day clinical course of type 1 diabetes mellitus after 30 years' duration: the diabetes control and complications trial\/epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience (1983-2005)","volume":"169","author":"Nathan","year":"2009","journal-title":"Archives of Internal Medicine"},{"issue":"5","key":"10.1002\/14651858.CD010137.pub2-BIB0092|cit94","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1002\/mrm.22716","article-title":"T1 mapping of the gadolinium-enhanced myocardium: adjustment for factors affecting interpatient comparison","volume":"65","author":"Gai","year":"2011","journal-title":"Magnetic Resonance in Medicine"},{"issue":"1","key":"10.1002\/14651858.CD010137.pub2-BIB0093|cit95","doi-asserted-by":"crossref","first-page":"44","DOI":"10.2337\/dc13-2148","article-title":"The diabetes control and complications trial\/epidemiology of diabetes interventions and complications study at 30 years: summary and future directions","volume":"37","author":"Gubitosi-Klug","year":"2014","journal-title":"Diabetes Care"},{"issue":"1-2","key":"10.1002\/14651858.CD010137.pub2-BIB0094|cit96","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jneuroim.2007.01.009","article-title":"Antibodies to GAD65 and peripheral nerve function in the DCCT","volume":"185","author":"Hoeldtke","year":"2007","journal-title":"Journal of Neuroimmunology"},{"issue":"10","key":"10.1002\/14651858.CD010137.pub2-BIB0095|cit97","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.2337\/dc12-2109","article-title":"The long-term effects of type 1 diabetes treatment and complications on health-related quality of life: a 23-year follow-up of the Diabetes Control and Complications\/Epidemiology of Diabetes Interventions and Complications cohort","volume":"36","author":"Jacobson","year":"2013","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1002\/14651858.CD010137.pub2-BIB0096|cit98","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.jdiacomp.2013.06.002","article-title":"Apolipoprotein-defined lipoproteins and apolipoproteins: associations with abnormal albuminuria in type 1 diabetes in the diabetes control and complications trial\/epidemiology of diabetes interventions and complications cohort","volume":"27","author":"Jenkins","year":"2013","journal-title":"Journal of Diabetes & its Complications"},{"issue":"11","key":"10.1002\/14651858.CD010137.pub2-BIB0097|cit99","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.2337\/dc08-0864","article-title":"A1C variability and the risk of microvascular complications in type 1 diabetes: data from the Diabetes Control and Complications Trial","volume":"31","author":"Kilpatrick","year":"2008","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1002\/14651858.CD010137.pub2-BIB0098|cit100","doi-asserted-by":"crossref","first-page":"701","DOI":"10.2337\/dc13-1746","article-title":"Effect of glycemic treatment and microvascular complications on menopause in women with type 1 diabetes in the Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications (DCCT\/EDIC) cohort","volume":"37","author":"Kim","year":"2014","journal-title":"Diabetes Care"},{"issue":"10","key":"10.1002\/14651858.CD010137.pub2-BIB0099|cit101","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.metabol.2014.07.001","article-title":"Decreased plasma levels of select very long chain ceramide species are associated with the development of nephropathy in type 1 diabetes","volume":"63","author":"Klein","year":"2014","journal-title":"Metabolism: Clinical & Experimental"},{"issue":"11","key":"10.1002\/14651858.CD010137.pub2-BIB0100|cit102","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1111\/dme.12296","article-title":"Concordance of retinopathy and nephropathy over time in Type 1 diabetes: an analysis of data from the Diabetes Control and Complications Trial","volume":"30","author":"Kramer","year":"2013","journal-title":"Diabetic Medicine"},{"issue":"2","key":"10.1002\/14651858.CD010137.pub2-BIB0101|cit103","doi-asserted-by":"crossref","first-page":"739","DOI":"10.2337\/db13-0881","article-title":"Impact of C-peptide preservation on metabolic and clinical outcomes in the Diabetes Control and Complications Trial","volume":"63","author":"Lachin","year":"2014","journal-title":"Diabetes"},{"issue":"4","key":"10.1002\/14651858.CD010137.pub2-BIB0102|cit104","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1464-5491.2010.02972.x","article-title":"Disparity in management of diabetes and coronary heart disease risk factors by sex in DCCT\/EDIC","volume":"27","author":"Larkin","year":"2010","journal-title":"Diabetic Medicine"},{"issue":"7","key":"10.1002\/14651858.CD010137.pub2-BIB0103|cit105","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.2337\/dc09-2245","article-title":"Dietary intake of eicosapentaenoic and docosahexaenoic acid and diabetic nephropathy: cohort analysis of the Diabetes Control and Complications Trial","volume":"33","author":"Lee","year":"2010","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1002\/14651858.CD010137.pub2-BIB0104|cit106","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1681\/ASN.V451159","article-title":"Glomerular filtration rate measurements in clinical trials. Modification of Diet in Renal Disease Study Group and the Diabetes Control and Complications Trial Research Group","volume":"4","author":"Levey","year":"1993","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Abstracts","key":"10.1002\/14651858.CD010137.pub2-BIB0105|cit107","first-page":"325A","article-title":"Inflammation and progressive nephropathy in the diabetes complication and control trial (DCCT) [abstract no: F-PO1015]","volume":"18","author":"Lin","year":"2007","journal-title":"Journal of the American Society of Nephrology"},{"issue":"8","key":"10.1002\/14651858.CD010137.pub2-BIB0106|cit108","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.2337\/dc12-2521","article-title":"Baseline markers of inflammation are associated with progression to macroalbuminuria in type 1 diabetic subjects","volume":"36","author":"Lopes-Virella","year":"2013","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1002\/14651858.CD010137.pub2-BIB0107|cit109","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1093\/ndt\/gfr454","article-title":"High levels of oxidized LDL in circulating immune complexes are associated with increased odds of developing abnormal albuminuria in Type 1 diabetes","volume":"27","author":"Lopes-Virella","year":"2012","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"10","key":"10.1002\/14651858.CD010137.pub2-BIB0108|cit110","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1111\/dme.12504","article-title":"Insulin secretion measured by stimulated C-peptide in long-established Type 1 diabetes in the Diabetes Control and Complications Trial (DCCT)\/ Epidemiology of Diabetes Interventions and Complications (EDIC) cohort: a pilot study","volume":"31","author":"McGee","year":"2014","journal-title":"Diabetic Medicine"},{"issue":"7","key":"10.1002\/14651858.CD010137.pub2-BIB0109|cit111","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.2337\/dc09-1098","article-title":"Development and progression of renal insufficiency with and without albuminuria in adults with type 1 diabetes in the diabetes control and complications trial and the epidemiology of diabetes interventions and complications study","volume":"33","author":"Molitch","year":"2010","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1002\/14651858.CD010137.pub2-BIB0110|cit112","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1373\/clinchem.2010.150250","article-title":"Determining stability of stored samples retrospectively: the validation of glycated albumin","volume":"57","author":"Nathan","year":"2011","journal-title":"Clinical Chemistry"},{"issue":"2","key":"10.1002\/14651858.CD010137.pub2-BIB0111|cit113","doi-asserted-by":"crossref","first-page":"607","DOI":"10.2337\/db10-0296","article-title":"Progression of carotid artery intima-media thickness during 12 years in the Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications (DCCT\/EDIC) study","volume":"60","author":"Polak","year":"2011","journal-title":"Diabetes"},{"issue":"1","key":"10.1002\/14651858.CD010137.pub2-BIB0113|cit114","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/0197-2456(93)90048-I","article-title":"Operational and policy considerations of data monitoring in clinical trials: the Diabetes Control and Complications Trial experience","volume":"14","author":"Siebert","year":"1993","journal-title":"Controlled Clinical Trials"},{"issue":"Oct","key":"10.1002\/14651858.CD010137.pub2-BIB0114|cit115","first-page":"569A","article-title":"The utility of serum creatinine based formulas in predicting the glomerular filtration rate in Type 1 diabetics with normal serum creatinine [abstract no: SU-PO169]","volume":"15","author":"Tello","year":"2004","journal-title":"Journal of the American Society of Nephrology"},{"issue":"16","key":"10.1002\/14651858.CD010137.pub2-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1161\/CIRCULATIONAHA.111.022327","article-title":"Myocardial structure, function, and scar in patients with type 1 diabetes mellitus","volume":"124","author":"Turkbey","year":"2011","journal-title":"Circulation"},{"issue":"12","key":"10.1002\/14651858.CD010137.pub2-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1001\/archopht.126.12.1707","article-title":"Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type 1 diabetes mellitus: 10 years after the Diabetes Control and Complications Trial","volume":"126","author":"White","year":"2008","journal-title":"Archives of Ophthalmology"},{"issue":"5","key":"10.1002\/14651858.CD010137.pub2-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.2337\/db09-1216","article-title":"Effect of prior intensive therapy in type 1 diabetes on 10-year progression of retinopathy in the DCCT\/EDIC: comparison of adults and adolescents","volume":"59","author":"White","year":"2010","journal-title":"Diabetes"},{"issue":"7","key":"10.1002\/14651858.CD010137.pub2-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.2215\/CJN.07901109","article-title":"Comparison of urinary albumin-creatinine ratio and albumin excretion rate in the diabetes control and complications trial\/epidemiology of diabetes interventions and complications study","volume":"5","author":"Younes","year":"2010","journal-title":"Clinical Journal of the American Society of Nephrology: CJASN"},{"issue":"10","key":"10.1002\/14651858.CD010137.pub2-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1681\/ASN.2013091004","article-title":"Renal outcomes in patients with type 1 diabetes and macroalbuminuria","volume":"25","author":"Boer","year":"2014","journal-title":"Journal of the American Society of Nephrology"},{"issue":"5","key":"10.1002\/14651858.CD010137.pub2-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1001\/archinternmed.2011.16","article-title":"Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: an analysis of the Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications cohort","volume":"171","author":"Boer","year":"2011","journal-title":"Archives of Internal Medicine"},{"issue":"Abstracts","key":"10.1002\/14651858.CD010137.pub2-BIB0122|cit122","first-page":"2B","article-title":"Effects of intensive diabetes therapy on glomerular filtration rate of type 1 diabetes: results from the DCCT\/EDIC [Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications study] [abstract no: LB-OR05]","volume":"22","author":"Boer","year":"2011","journal-title":"Journal of the American Society of Nephrology"},{"issue":"8519","key":"10.1002\/14651858.CD010137.pub2-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/S0140-6736(86)91433-9","article-title":"Effect of two years of strict metabolic control on progression of incipient nephropathy in insulin-dependent diabetes","volume":"2","author":"Feldt-Rasmussen","year":"1986","journal-title":"Lancet"},{"issue":"11","key":"10.1002\/14651858.CD010137.pub2-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1056\/NEJM198603133141101","article-title":"Kidney function during 12 months of strict metabolic control in insulin-dependent diabetic patients with incipient nephropathy","volume":"314","author":"Feldt-Rasmussen","year":"1986","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD010137.pub2-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0168-8227(95)01064-K","article-title":"Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study","volume":"28","author":"Ohkubo","year":"1995","journal-title":"Diabetes Research & Clinical Practice"},{"key":"10.1002\/14651858.CD010137.pub2-BIB0126|cit126","first-page":"B21","article-title":"Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients","volume":"23 Suppl 2","author":"Shichiri","year":"2000","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1002\/14651858.CD010137.pub2-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0168-8227(00)00122-4","article-title":"Cost-effectiveness of intensive insulin therapy for type 2 diabetes: a 10-year follow-up of the Kumamoto study","volume":"48","author":"Wake","year":"2000","journal-title":"Diabetes Research & Clinical Practice"},{"issue":"3","key":"10.1002\/14651858.CD010137.pub2-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.diabres.2011.05.008","article-title":"Multifactorial intervention in individuals with type 2 diabetes and microalbuminuria: the Microalbuminuria Education and Medication Optimisation (MEMO) study","volume":"93","author":"Crasto","year":"2011","journal-title":"Diabetes Research & Clinical Practice"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD010137.pub2-BIB0129|cit129","first-page":"166","article-title":"Impact of intensive multi-factorial intervention on novel markers of inflammation and vascular stiffness [abstract no: P446]","volume":"28","author":"Crasto","year":"2011","journal-title":"Diabetic Medicine"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD010137.pub2-BIB0130|cit130","first-page":"160","article-title":"Interim analysis of the effects of a multifactorial intervention in people with type 2 diabetes and microalbuminuria after twelve months [abstract no: P410]","volume":"26","author":"Crasto","year":"2009","journal-title":"Diabetic Medicine"},{"issue":"6556","key":"10.1002\/14651858.CD010137.pub2-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1136\/bmj.293.6556.1195","article-title":"Effect of near normoglycaemia for two years on progression of early diabetic retinopathy, nephropathy, and neuropathy: the Oslo study","volume":"293","author":"Dahl-Jorgensen","year":"1986","journal-title":"British Medical Journal Clinical Research Ed"},{"issue":"1","key":"10.1002\/14651858.CD010137.pub2-BIB0132|cit132","first-page":"19","article-title":"Reduction of urinary albumin excretion after 4 years of continuous subcutaneous insulin infusion in insulin-dependent diabetes mellitus. The Oslo Study","volume":"117","author":"Dahl-Jorgensen","year":"1988","journal-title":"Acta Endocrinologica"},{"issue":"1","key":"10.1002\/14651858.CD010137.pub2-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1046\/j.1365-2796.1999.00402.x","article-title":"Decreased heart rate variability in patients with type 1 diabetes mellitus is related to arterial wall stiffness","volume":"245","author":"Jensen-Urstad","year":"1999","journal-title":"Journal of Internal Medicine"},{"issue":"6","key":"10.1002\/14651858.CD010137.pub2-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1046\/j.1365-2362.2003.01126.x","article-title":"Influence of glucose control, lipoproteins, and haemostasis function on brachial endothelial reactivity and carotid intima-media area, stiffness and diameter in Type 1 diabetes mellitus patients","volume":"33","author":"Johansson","year":"2003","journal-title":"European Journal of Clinical Investigation"},{"issue":"8","key":"10.1002\/14651858.CD010137.pub2-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1007\/s00125-014-3248-2","article-title":"Intensified insulin treatment is associated with improvement in skin microcirculation and ischaemic foot ulcer in patients with type 1 diabetes mellitus: a long-term follow-up study","volume":"57","author":"Rathsman","year":"2014","journal-title":"Diabetologia"},{"issue":"2","key":"10.1002\/14651858.CD010137.pub2-BIB0145|cit136","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0168-8227(92)90087-8","article-title":"Risk factors for progression of microvascular complications in the Stockholm Diabetes Intervention Study (SDIS)","volume":"16","author":"Reichard","year":"1992","journal-title":"Diabetes Research & Clinical Practice"},{"issue":"2","key":"10.1002\/14651858.CD010137.pub2-BIB0136|cit137","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1365-2796.1991.tb00415.x","article-title":"Intensified conventional insulin treatment retards the microvascular complications of insulin-dependent diabetes mellitus (IDDM): the Stockholm Diabetes Intervention Study (SDIS) after 5 years","volume":"230","author":"Reichard","year":"1991","journal-title":"Journal of Internal Medicine"},{"issue":"5","key":"10.1002\/14651858.CD010137.pub2-BIB0137|cit138","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/j.1365-2796.1990.tb00271.x","article-title":"Metabolic control and complications over 3 years in patients with insulin dependent diabetes (IDDM): the Stockholm Diabetes Intervention Study (SDIS)","volume":"228","author":"Reichard","year":"1990","journal-title":"Journal of Internal Medicine"},{"issue":"2","key":"10.1002\/14651858.CD010137.pub2-BIB0138|cit139","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.0954-6820.1988.tb16748.x","article-title":"The Stockholm Diabetes Intervention Study (SDIS): 18 months' results","volume":"224","author":"Reichard","year":"1988","journal-title":"Acta Medica Scandinavica"},{"issue":"12","key":"10.1002\/14651858.CD010137.pub2-BIB0139|cit140","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1046\/j.1464-5491.2000.00398.x","article-title":"Autonomic neuropathy--a complication less pronounced in patients with type 1 diabetes mellitus who have lower blood glucose levels","volume":"17","author":"Reichard","year":"2000","journal-title":"Diabetic Medicine"},{"issue":"5","key":"10.1002\/14651858.CD010137.pub2-BIB0140|cit141","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1056\/NEJM199307293290502","article-title":"The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus","volume":"329","author":"Reichard","year":"1993","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD010137.pub2-BIB0142|cit142","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2337\/diab.43.2.313","article-title":"Mortality and treatment side-effects during long-term intensified conventional insulin treatment in the Stockholm Diabetes Intervention Study","volume":"43","author":"Reichard","year":"1994","journal-title":"Diabetes"},{"issue":"12","key":"10.1002\/14651858.CD010137.pub2-BIB0141|cit143","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1007\/s001250050602","article-title":"Complications in IDDM are caused by elevated blood glucose level: the Stockholm Diabetes Intervention Study (SDIS) at 10-year follow up","volume":"39","author":"Reichard","year":"1996","journal-title":"Diabetologia"},{"issue":"2","key":"10.1002\/14651858.CD010137.pub2-BIB0143|cit144","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1365-2796.1989.tb01359.x","article-title":"Nephropathy is delayed by intensified insulin treatment in patients with insulin-dependent diabetes mellitus and retinopathy","volume":"226","author":"Reichard","year":"1989","journal-title":"Journal of Internal Medicine"},{"issue":"6","key":"10.1002\/14651858.CD010137.pub2-BIB0144|cit145","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1177\/014572179402000607","article-title":"Changes in conceptions and attitudes during five years of intensified conventional insulin treatment in the Stockholm Diabetes Intervention Study (SDIS)","volume":"20","author":"Reichard","year":"1994","journal-title":"Diabetes Educator"},{"issue":"6","key":"10.1002\/14651858.CD010137.pub2-BIB0146|cit146","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJMoa0706245","article-title":"Effect of a multifactorial intervention on mortality in type 2 diabetes","volume":"358","author":"Gaede","year":"2008","journal-title":"New England Journal of Medicine"},{"issue":"Abstracts","key":"10.1002\/14651858.CD010137.pub2-BIB0147|cit147","first-page":"43A","article-title":"Multifactorial intervention in patients with type 2 diabetes: long-term effects on mortality and vascular complications [abstract no: SA-FC042]","volume":"18","author":"Gaede","year":"2007","journal-title":"Journal of the American Society of Nephrology"},{"issue":"8","key":"10.1002\/14651858.CD010137.pub2-BIB0148|cit148","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.2337\/dc07-2452","article-title":"Cost-effectiveness of intensified versus conventional multifactorial intervention in type 2 diabetes: results and projections from the Steno-2 study","volume":"31","author":"Gaede","year":"2008","journal-title":"Diabetes Care"},{"issue":"September, Prog","key":"10.1002\/14651858.CD010137.pub2-BIB0149|cit149","first-page":"72a","article-title":"The STENO-2 study: intensified multifactorial intervention reduces the risk of cardiovascular disease in patients with type 2 diabetes and microalbuminuria [abstract no: F-FC031]","volume":"13","author":"Gaede","year":"2002","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1002\/14651858.CD010137.pub2-BIB0150|cit150","unstructured":"Gaede P Vedel P Larsen N Jensen G Parving HH Pedersen O The Steno-2 study: intensified multifactorial intervention reduces the risk of cardiovascular disease in patients with type 2 diabetes and microalbuminuria [abstract no: 181] 38th Annual Meeting of the European Association for the Study of Diabetes (EASD); 2002 Sept 1-5; Budapest, Hungary 2002"},{"issue":"5","key":"10.1002\/14651858.CD010137.pub2-BIB0151|cit151","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1056\/NEJMoa021778","article-title":"Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes","volume":"348","author":"Gaede","year":"2003","journal-title":"New England Journal of Medicine"},{"issue":"9","key":"10.1002\/14651858.CD010137.pub2-BIB0152|cit152","first-page":"1357","article-title":"Intensive multifactorial intervention in NIDDM patients with persistent microalbuminuria [abstract]","volume":"7","author":"Gaede","year":"1996","journal-title":"Journal of the American Society of Nephrology"},{"issue":"9153","key":"10.1002\/14651858.CD010137.pub2-BIB0153|cit153","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0140-6736(98)07368-1","article-title":"Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study","volume":"353","author":"Gaede","year":"1999","journal-title":"Lancet"},{"issue":"30","key":"10.1002\/14651858.CD010137.pub2-BIB0154|cit154","first-page":"4277","article-title":"Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno-2 study","volume":"161","author":"Gaede","year":"1999","journal-title":"Ugeskrift for Laeger"},{"issue":"8264","key":"10.1002\/14651858.CD010137.pub2-BIB0155|cit155","first-page":"121","article-title":"Effect of 6 months of strict metabolic control on eye and kidney function in insulin-dependent diabetics with background retinopathy. Steno Study Group","volume":"1","year":"1982","journal-title":"Lancet"},{"issue":"9131","key":"10.1002\/14651858.CD010137.pub2-BIB0156|cit156","first-page":"837","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.[Erratum appears in Lancet 1999 Aug;354(9178):602]","volume":"352","year":"1998","journal-title":"Lancet"},{"issue":"12","key":"10.1002\/14651858.CD010137.pub2-BIB0158|cit157","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/BF00400195","article-title":"UK Prospective Diabetes Study (UKPDS). VIII. Study design, progress and performance","volume":"34","year":"1991","journal-title":"Diabetologia"},{"issue":"1 pt 2","key":"10.1002\/14651858.CD010137.pub2-BIB0157|cit158","doi-asserted-by":"crossref","first-page":"136","DOI":"10.7326\/0003-4819-124-1_Part_2-199601011-00011","article-title":"United Kingdom Prospective Diabetes Study 17: a 9-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus","volume":"124","author":"Turner","year":"1996","journal-title":"Annals of Internal Medicine"},{"issue":"2","key":"10.1002\/14651858.CD010137.pub2-BIB0159|cit159","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1001\/archinte.1997.00440230053007","article-title":"Cardiovascular events and correlates in the Veterans Affairs Diabetes Feasibility Trial. Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes","volume":"157","author":"Abraira","year":"1997","journal-title":"Archives of Internal Medicine"},{"issue":"8","key":"10.1002\/14651858.CD010137.pub2-BIB0160|cit160","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.2337\/diacare.18.8.1113","article-title":"Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Veterans Affairs Cooperative Study in Type II Diabetes","volume":"18","author":"Abraira","year":"1995","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1002\/14651858.CD010137.pub2-BIB0161|cit161","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.2337\/diacare.15.11.1560","article-title":"Glycemic control and complications in type II diabetes. Design of a feasibility trial. VA CS Group (CSDM)","volume":"15","author":"Abraira","year":"1992","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1002\/14651858.CD010137.pub2-BIB0162|cit162","doi-asserted-by":"crossref","first-page":"574","DOI":"10.2337\/diacare.21.4.574","article-title":"Response to intensive therapy steps and to glipizide dose in combination with insulin in type 2 diabetes. VA feasibility study on glycemic control and complications (VA CSDM)","volume":"21","author":"Abraira","year":"1998","journal-title":"Diabetes Care"},{"issue":"5 Pt 1","key":"10.1002\/14651858.CD010137.pub2-BIB0163|cit163","doi-asserted-by":"crossref","first-page":"S360","DOI":"10.1016\/S0002-8703(99)70036-0","article-title":"Intensive insulin therapy in patients with type 2 diabetes: implications of the Veterans affairs (VA CSDM) feasibility trial","volume":"138","author":"Abraira","year":"1999","journal-title":"American Heart Journal"},{"issue":"4","key":"10.1002\/14651858.CD010137.pub2-BIB0164|cit164","doi-asserted-by":"crossref","first-page":"510","DOI":"10.2337\/diacare.21.4.510","article-title":"Ethnic differences in the glycemic response to exogenous insulin treatment in the Veterans Affairs Cooperative Study in Type 2 Diabetes Mellitus (VA CSDM)","volume":"21","author":"Agrawal","year":"1998","journal-title":"Diabetes Care"},{"issue":"5-6","key":"10.1002\/14651858.CD010137.pub2-BIB0165|cit165","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S1056-8727(99)00062-8","article-title":"The effects of intensive glycemic control on neuropathy in the VA cooperative study on type II diabetes mellitus (VA CSDM)","volume":"13","author":"Azad","year":"1999","journal-title":"Journal of Diabetes & its Complications"},{"issue":"22","key":"10.1002\/14651858.CD010137.pub2-BIB0166|cit166","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1001\/archinte.158.22.2485","article-title":"Effect of intensive glycemic control on fibrinogen, lipids, and lipoproteins: Veterans Affairs Cooperative Study in Type II Diabetes Mellitus","volume":"158","author":"Emanuele","year":"1998","journal-title":"Archives of Internal Medicine"},{"issue":"12","key":"10.1002\/14651858.CD010137.pub2-BIB0167|cit167","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.2337\/diacare.19.12.1375","article-title":"Evaluations of retinopathy in the VA Cooperative Study on Glycemic Control and Complications in Type II Diabetes (VA CSDM). A feasibility study","volume":"19","author":"Emanuele","year":"1996","journal-title":"Diabetes Care"},{"issue":"10","key":"10.1002\/14651858.CD010137.pub2-BIB0168|cit168","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.2337\/diacare.23.10.1478","article-title":"Effect of intensive glycemic control on microalbuminuria in type 2 diabetes. Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type 2 Diabetes Feasibility Trial Investigators","volume":"23","author":"Levin","year":"2000","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1002\/14651858.CD010137.pub2-BIB0169|cit169","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jdiacomp.2004.12.002","article-title":"Health-related quality of life in the VA Feasibility Study on glycemic control and complications in type 2 diabetes mellitus","volume":"19","author":"Pitale","year":"2005","journal-title":"Journal of Diabetes & its Complications"},{"issue":"9","key":"10.1002\/14651858.CD010137.pub2-BIB0170|cit170","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.2337\/diacare.23.9.1316","article-title":"Two years of intensive glycemic control and left ventricular function in the Veterans Affairs Cooperative Study in Type 2 Diabetes Mellitus (VA CSDM)","volume":"23","author":"Pitale","year":"2000","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1002\/14651858.CD010137.pub2-BIB0171|cit171","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S1056-8727(02)00277-5","article-title":"Design of the cooperative study on glycemic control and complications in diabetes mellitus type 2: Veterans Affairs Diabetes Trial","volume":"17","author":"Abraira","year":"2003","journal-title":"Journal of Diabetes & its Complications"},{"issue":"2","key":"10.1002\/14651858.CD010137.pub2-BIB0172|cit172","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1463-1326.2008.00933.x","article-title":"Glycaemic separation and risk factor control in the Veterans Affairs Diabetes Trial: an interim report","volume":"11","author":"Abraira","year":"2009","journal-title":"Diabetes, Obesity & Metabolism"},{"issue":"9","key":"10.1002\/14651858.CD010137.pub2-BIB0173|cit173","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.2337\/dc11-0175","article-title":"Observation on renal outcomes in the Veterans Affairs Diabetes Trial","volume":"34","author":"Agrawal","year":"2011","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1002\/14651858.CD010137.pub2-BIB0174|cit174","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.atherosclerosis.2013.03.024","article-title":"Relationship between vitamin D status and incidence of vascular events in the Veterans Affairs Diabetes Trial","volume":"228","author":"Alele","year":"2013","journal-title":"Atherosclerosis"},{"issue":"10","key":"10.1002\/14651858.CD010137.pub2-BIB0175|cit175","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.2337\/dc14-0284","article-title":"Blood pressure and pulse pressure effects on renal outcomes in the Veterans Affairs Diabetes Trial (VADT)","volume":"37","author":"Anderson","year":"2014","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1002\/14651858.CD010137.pub2-BIB0176|cit176","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2337\/dc10-1420","article-title":"Blood pressure and cardiovascular disease risk in the Veterans Affairs Diabetes Trial","volume":"34","author":"Anderson","year":"2011","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1002\/14651858.CD010137.pub2-BIB0177|cit177","doi-asserted-by":"crossref","first-page":"501","DOI":"10.2337\/dc13-1193","article-title":"Association of PAI-1 and fibrinogen with diabetic retinopathy in the Veterans Affairs Diabetes Trial (VADT)","volume":"37","author":"Azad","year":"2014","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1002\/14651858.CD010137.pub2-BIB0178|cit178","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1007\/s00125-014-3199-7","article-title":"Association of blood glucose control and pancreatic reserve with diabetic retinopathy in the Veterans Affairs Diabetes Trial (VADT)","volume":"57","author":"Azad","year":"2014","journal-title":"Diabetologia"},{"issue":"6","key":"10.1002\/14651858.CD010137.pub2-BIB0179|cit179","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.jdiacomp.2013.05.005","article-title":"Apolipoprotein-defined and NMR lipoprotein subclasses in the veterans affairs diabetes trial","volume":"27","author":"Azar","year":"2013","journal-title":"Journal of Diabetes & its Complications"},{"issue":"2","key":"10.1002\/14651858.CD010137.pub2-BIB0180|cit180","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJMoa0808431","article-title":"Glucose control and vascular complications in veterans with type 2 diabetes.[Erratum appears in N Engl J Med. 2009 Sep 3;361(10):1028], [Erratum appears in N Engl J Med. 2009 Sep 3;361(10):1024-5; PMID: 19726779]","volume":"360","author":"Duckworth","year":"2009","journal-title":"New England Journal of Medicine"},{"issue":"6","key":"10.1002\/14651858.CD010137.pub2-BIB0181|cit181","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jdiacomp.2011.10.003","article-title":"The duration of diabetes affects the response to intensive glucose control in type 2 subjects: the VA Diabetes Trial","volume":"25","author":"Duckworth","year":"2011","journal-title":"Journal of Diabetes & its Complications"},{"issue":"5","key":"10.1002\/14651858.CD010137.pub2-BIB0182|cit182","doi-asserted-by":"crossref","first-page":"942","DOI":"10.2337\/diacare.24.5.942","article-title":"Glucose control and cardiovascular complications: the VA Diabetes Trial","volume":"24","author":"Duckworth","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1002\/14651858.CD010137.pub2-BIB0183|cit183","doi-asserted-by":"crossref","first-page":"85","DOI":"10.4158\/EP.12.S1.85","article-title":"Control of cardiovascular risk factors in the Veterans Affairs Diabetes Trial in advanced type 2 diabetes","volume":"12 Suppl 1","author":"Duckworth","year":"2006","journal-title":"Endocrine Practice"},{"issue":"5","key":"10.1002\/14651858.CD010137.pub2-BIB0184|cit184","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jdiacomp.2008.02.010","article-title":"Comparison of dilated fundus examinations with seven-field stereo fundus photographs in the Veterans Affairs Diabetes Trial","volume":"23","author":"Emanuele","year":"2009","journal-title":"Journal of Diabetes & its Complications"},{"issue":"2","key":"10.1002\/14651858.CD010137.pub2-BIB0185|cit185","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.diabres.2009.08.001","article-title":"Ethnicity, race, and clinically significant macular edema in the Veterans Affairs Diabetes Trial (VADT)","volume":"86","author":"Emanuele","year":"2009","journal-title":"Diabetes Research & Clinical Practice"},{"issue":"8","key":"10.1002\/14651858.CD010137.pub2-BIB0186|cit186","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.2337\/diacare.28.8.1954","article-title":"Ethnicity, race, and baseline retinopathy correlates in the veterans affairs diabetes trial","volume":"28","author":"Emanuele","year":"2005","journal-title":"Diabetes Care"},{"issue":"23","key":"10.1002\/14651858.CD010137.pub2-BIB0187|cit187","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1056\/NEJMoa1414266","article-title":"Follow-up of glycemic control and cardiovascular outcomes in type 2 diabetes.[Erratum appears in N Engl J Med. 2015 Jul 9;373(2):198; PMID: 26154808]","volume":"372","author":"Hayward","year":"2015","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD010137.pub2-BIB0188|cit188","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jdiacomp.2014.01.008","article-title":"Clinical correlates of serum pigment epithelium-derived factor in type 2 diabetes patients","volume":"28","author":"Jenkins","year":"2014","journal-title":"Journal of Diabetes & its Complications"},{"issue":"2","key":"10.1002\/14651858.CD010137.pub2-BIB0189|cit189","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jdiacomp.2005.06.013","article-title":"The association between metabolic control and prevalent macrovascular disease in Type 2 diabetes: the VA Cooperative Study in diabetes","volume":"20","author":"Kirkman","year":"2006","journal-title":"Journal of Diabetes & its Complications"},{"issue":"8","key":"10.1002\/14651858.CD010137.pub2-BIB0190|cit190","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.2337\/dc12-2082","article-title":"The effect of intensive glucose lowering on lipoprotein particle profiles and inflammatory markers in the Veterans Affairs Diabetes Trial (VADT)","volume":"36","author":"Koska","year":"2013","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1002\/14651858.CD010137.pub2-BIB0191|cit191","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.atherosclerosis.2012.08.006","article-title":"The levels of MDA-LDL in circulating immune complexes predict myocardial infarction in the VADT study","volume":"224","author":"Lopes-Virella","year":"2012","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1002\/14651858.CD010137.pub2-BIB0192|cit192","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.amjcard.2006.01.061","article-title":"Baseline achievement of lipid goals and usage of lipid medications in patients with diabetes mellitus (from the Veterans Affairs Diabetes Trial)","volume":"98","author":"Meyers","year":"2006","journal-title":"American Journal of Cardiology"},{"issue":"10","key":"10.1002\/14651858.CD010137.pub2-BIB0193|cit193","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1056\/NEJMc096250","article-title":"Veterans Affairs diabetes trial--corrections.[Erratum for N Engl J Med. 2009 Jan 8;360(2):129-39; PMID: 19092145]","volume":"361","author":"Moritz","year":"2009","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"10.1002\/14651858.CD010137.pub2-BIB0194|cit194","doi-asserted-by":"crossref","first-page":"952","DOI":"10.2337\/dc07-1926","article-title":"Proliferative diabetic retinopathy in type 2 diabetes is related to coronary artery calcium in the Veterans Affairs Diabetes Trial (VADT)","volume":"31","author":"Reaven","year":"2008","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1002\/14651858.CD010137.pub2-BIB0195|cit195","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.2337\/db09-0618","article-title":"Intensive glucose-lowering therapy reduces cardiovascular disease events in veterans affairs diabetes trial participants with lower calcified coronary atherosclerosis","volume":"58","author":"Reaven","year":"2009","journal-title":"Diabetes"},{"issue":"2","key":"10.1002\/14651858.CD010137.pub2-BIB0196|cit196","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.atherosclerosis.2008.07.031","article-title":"Association between IL-6 and the extent of coronary atherosclerosis in the veterans affairs diabetes trial (VADT)","volume":"203","author":"Saremi","year":"2009","journal-title":"Atherosclerosis"},{"issue":"11","key":"10.1002\/14651858.CD010137.pub2-BIB0197|cit197","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.2337\/dc12-0464","article-title":"Progression of vascular calcification is increased with statin use in the Veterans Affairs Diabetes Trial (VADT)","volume":"35","author":"Saremi","year":"2012","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1002\/14651858.CD010137.pub2-BIB0198|cit198","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.2337\/dc10-1388","article-title":"Rates and determinants of coronary and abdominal aortic artery calcium progression in the Veterans Affairs Diabetes Trial (VADT)","volume":"33","author":"Saremi","year":"2010","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1002\/14651858.CD010137.pub2-BIB0199|cit199","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.metabol.2014.10.010","article-title":"The effect of intensive glucose lowering therapy among major racial\/ethnic groups in the Veterans Affairs Diabetes Trial","volume":"64","author":"Saremi","year":"2015","journal-title":"Metabolism: Clinical & Experimental"},{"issue":"2","key":"10.1002\/14651858.CD010137.pub2-BIB0200|cit200","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.metabol.2010.02.003","article-title":"Increased plasma basic fibroblast growth factor is associated with coronary heart disease in adult type 2 diabetes mellitus","volume":"60","author":"Zimering","year":"2011","journal-title":"Metabolism: Clinical & Experimental"},{"issue":"11","key":"10.1002\/14651858.CD010137.pub2-BIB0201|cit201","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/j.metabol.2008.06.012","article-title":"Plasma basic fibroblast growth factor is correlated with plasminogen activator inhibitor-1 concentration in adults from the Veterans Affairs Diabetes Trial","volume":"57","author":"Zimering","year":"2008","journal-title":"Metabolism: Clinical & Experimental"},{"issue":"6","key":"10.1002\/14651858.CD010137.pub2-BIB0202|cit202","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.metabol.2009.02.023","article-title":"Endothelial cell inhibitory autoantibodies are associated with laser photocoagulation in adults from the Veterans Affairs Diabetes Trial","volume":"58","author":"Zimering","year":"2009","journal-title":"Metabolism: Clinical & Experimental"},{"issue":"3","key":"10.1002\/14651858.CD010137.pub2-BIB0203|cit203","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.metabol.2008.10.014","article-title":"Low plasma basic fibroblast growth factor is associated with laser photocoagulation treatment in adult type 2 diabetes mellitus from the Veterans Affairs Diabetes Trial","volume":"58","author":"Zimering","year":"2009","journal-title":"Metabolism: Clinical & Experimental"},{"issue":"6","key":"10.1002\/14651858.CD010137.pub2-BIB0204|cit204","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1210\/jc.2008-2354","article-title":"Autoantibodies in type 2 diabetes induce stress fiber formation and apoptosis in endothelial cells","volume":"94","author":"Zimering","year":"2009","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"issue":"3","key":"10.1002\/14651858.CD010137.pub2-BIB0205|cit205","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0891-6632(87)80065-X","article-title":"Near normoglycemia for 1 year has no effect on platelet reactivity, factor VIII, and von Willebrand factor in insulin-dependent diabetes mellitus: a controlled trial","volume":"1","author":"Christiansen","year":"1987","journal-title":"Journal of Diabetic Complications"},{"issue":"8318","key":"10.1002\/14651858.CD010137.pub2-BIB0206|cit206","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/S0140-6736(83)92586-2","article-title":"Prevention of deterioration of renal and sensory-nerve function by more intensive management of insulin-dependent diabetic patients. A two-year randomised prospective study","volume":"1","author":"Holman","year":"1983","journal-title":"Lancet"},{"issue":"2-3","key":"10.1002\/14651858.CD010137.pub2-BIB0207|cit207","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0891-6632(91)90028-N","article-title":"Recent progress in the treatment of diabetic nephropathy: importance of strict glycemic control on the regression of diabetic nephropathy","volume":"5","author":"Kawamori","year":"1991","journal-title":"Journal of Diabetic Complications"},{"issue":"10","key":"10.1002\/14651858.CD010137.pub2-BIB0208|cit208","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1056\/NEJM198503073121004","article-title":"Effect of blood glucose control on increased glomerular filtration rate and kidney size in insulin-dependent diabetes","volume":"312","author":"Wiseman","year":"1985","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD010137.pub2-BIB0209|cit209","unstructured":"Centers for Disease Control and Prevention. National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention www.cdc.gov\/diabetes\/pubs\/pdf\/ndfs_2011.pdf"},{"issue":"5","key":"10.1002\/14651858.CD010137.pub2-BIB0210|cit210","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.2337\/diacare.26.5.1485","article-title":"Association of hypoglycemia and cardiac ischemia: a study based on continuous monitoring","volume":"26","author":"Desouza","year":"2003","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1002\/14651858.CD010137.pub2-BIB0211|cit211","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJMoa0808431","article-title":"Glucose control and vascular complications in veterans with type 2 diabetes.[Erratum appears in N Engl J Med. 2009 Sep 3;361(10):1028], [Erratum appears in N Engl J Med. 2009 Sep 3;361(10):1024-5; PMID: 19726779]","volume":"360","author":"Duckworth","year":"2009","journal-title":"New England Journal of Medicine"},{"issue":"14","key":"10.1002\/14651858.CD010137.pub2-BIB0212|cit212","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1001\/jama.294.14.1782","article-title":"Incidence of end-stage renal disease in patients with type 1 diabetes","volume":"294","author":"Finne","year":"2005","journal-title":"JAMA"},{"issue":"24","key":"10.1002\/14651858.CD010137.pub2-BIB0213|cit213","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa0802743","article-title":"Effects of intensive glucose lowering in type 2 diabetes","volume":"358","author":"Gerstein","year":"2008","journal-title":"New England Journal of Medicine"},{"issue":"7650","key":"10.1002\/14651858.CD010137.pub2-BIB0214|cit214","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD010137.pub2-BIB0215|cit215","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD010137.pub2-BIB0216|cit216","doi-asserted-by":"crossref","first-page":"d6898","DOI":"10.1136\/bmj.d6898","article-title":"Intensive glycaemic control for patients with type 2 diabetes: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials","volume":"343","author":"Hemmingsen","year":"2011","journal-title":"BMJ"},{"issue":"7414","key":"10.1002\/14651858.CD010137.pub2-BIB0217|cit217","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD010137.pub2-BIB0218|cit218","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD010137.pub2-BIB0219|cit219","unstructured":"International Diabetes Federation IDF Diabetes atlas (7th edition), 2015 www.diabetesatlas.org\/"},{"issue":"9739","key":"10.1002\/14651858.CD010137.pub2-BIB0220|cit220","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0140-6736(10)60576-4","article-title":"Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial.[Erratum appears in Lancet. 2010 Oct 30;376(9751):1466]","volume":"376","author":"Ismail-Beigi","year":"2010","journal-title":"Lancet"},{"issue":"19","key":"10.1002\/14651858.CD010137.pub2-BIB0221|cit221","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1056\/NEJM199505113321902","article-title":"Glycosylated hemoglobin and the risk of microalbuminuria in patients with insulin-dependent diabetes mellitus","volume":"332","author":"Krolewski","year":"1995","journal-title":"New England Journal of Medicine"},{"issue":"10","key":"10.1002\/14651858.CD010137.pub2-BIB0222|cit222","first-page":"1024\u20135","article-title":"Veterans affairs diabetes trial - corrections.[Erratum for N Engl J Med. 2009 Jan 8;360(2):129-39; PMID: 19092145]","volume":"361","author":"Moritz","year":"2009","journal-title":"New England Journal of Medicine"},{"issue":"9859","key":"10.1002\/14651858.CD010137.pub2-BIB0223|cit223","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/S0140-6736(12)61689-4","article-title":"Disability-adjusted life years(DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.[Erratum appears in Lancet. 2013 Feb 23;381(9867):628 Note: AlMazroa, Mohammad A [added]; Memish, Ziad A [added]]","volume":"380","author":"Murray","year":"2012","journal-title":"Lancet"},{"issue":"24","key":"10.1002\/14651858.CD010137.pub2-BIB0224|cit224","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","article-title":"Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes","volume":"358","author":"Patel","year":"2008","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD010137.pub2-BIB0225|cit225","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1547-5069.1998.tb01237.x","article-title":"Adapting to and managing diabetes","volume":"30","author":"Paterson","year":"1998","journal-title":"Image - the Journal of Nursing Scholarship"},{"issue":"296","key":"10.1002\/14651858.CD010137.pub2-BIB0226|cit226","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1001\/jama.296.4.421","article-title":"Effect of youth-onset type 2 diabetes mellitus on incidence of end-stage renal disease and mortality in young and middle-aged Pima Indians","volume":"26","author":"Pavkov","year":"2006","journal-title":"JAMA"},{"issue":"15","key":"10.1002\/14651858.CD010137.pub2-BIB0227|cit227","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1056\/NEJM199910073411506","article-title":"Nephropathy in patients with type 2 diabetes mellitus","volume":"341","author":"Ritz","year":"1999","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD010137.pub2-BIB0228|cit228","unstructured":"Sch\u00fcnemann HJ Oxman AD Higgins JP Vist GE Glasziou P Guyatt GH Chapter 11: Presenting results and 'Summary of findings' tables. In: Higgins JP, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD010137.pub2-BIB0229|cit229","unstructured":"Sch\u00fcnemann HJ Oxman AD Higgins JP Deeks JJ Glasziou P Guyatt GH Chapter 12: Interpreting results and drawing conclusions. In: Higgins JP, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"9131","key":"10.1002\/14651858.CD010137.pub2-BIB0230|cit230","first-page":"837","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.[Erratum appears in Lancet 1999 Aug 14;354(9178):602]","volume":"352","author":"UK Prospective Diabetes Study Group","year":"1998","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD010137.pub2-BIB0231|cit231","unstructured":"US Renal Data System USRDS 2011 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. National Institute of Health, National Institute of Diabetes and Digestive and Kidney Diseases. 2011 www.usrds.org\/atlas11.aspx"},{"key":"10.1002\/14651858.CD010137.pub2-BIB0232|cit232","unstructured":"US Renal Data System 2013 atlas of CKD and ESRD www.usrds.org\/atlas13.aspx"},{"issue":"5","key":"10.1002\/14651858.CD010137.pub2-BIB0233|cit233","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.2337\/diacare.27.5.1047","article-title":"Global prevalence of diabetes: estimates for the year 2000 and projections for 2030","volume":"27","author":"Wild","year":"2004","journal-title":"Diabetes Care"},{"issue":"10","key":"10.1002\/14651858.CD010137.pub2-BIB0234|cit234","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010137","article-title":"Glucose targets for preventing diabetic kidney disease and its progression","author":"Cosmo","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD010137.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T09:01:44Z","timestamp":1769418104000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD010137.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Kidney and Transplant Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,6,8]]},"references-count":234,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2017,6]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd010137.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,8]]}}}